Interleukin-22 reduces lung inflammation during influenza a virus infection and protects against secondary bacterial infection

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 6911-6924

  Ivanov, Stoyan ^a,b,c,d,k   Renneson, Joelle ^a,b,c,d   Fontaine, Josette ^a,b,c,d   Barthelemy, Adeline ^a,b,c,d   Paget, Christophe ^a,b,c,d   Fernandez, Elodie Macho ^a,b,c,d   Blanc, Fany ^c,e   Trez, Carl De ^f   Maele, Laurye Van ^a,b,c,d   Dumoutier, Laure ^g   Huerre, Michel René ^e,h   Eberl, Gérard ^e,i   Si Tahar, Mustapha ^c,e   Gosset, Pierre ^j   Renauld, Jean Christophe ^g   Sirard, Jean Claude ^a,b,c,d   Faveeuw, Christelle ^a,b,c,d   Trotteina, François ^a,b,c,d  

^a INSERM U1019   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

^d Institut Federatif de Recherche 142   (France)

^e INSTITUT PASTEUR   (France)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h Unite de Recherche et d'Expertise Histotechnologie et Pathologie   (France)

ⁱ CNRS   (France)

^j UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; INTERLEUKIN 22; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR GAMMA T; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; INFECTION PREVENTION; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; INNATE IMMUNITY; LETHALITY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; SECONDARY INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; BACTERIAL INFECTIONS; COINFECTION; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERLEUKINS; LUNG; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS;

EID: 84878528727     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02943-12     Document Type: Article

References (80)

1. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29:71-109.
2. Sonnenberg GF, Fouser LA, Artis D. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12:383-390.
3. Colonna M. 2009. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31:15-23.
4. + innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur. J. Immunol. 41:1075-1085.
5. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119:3573-3585.
6. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
7. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. 2009. Interleukin-17-producing γδT cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-330.
8. Spits H, Cupedo T. 2012. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30:647-675.
9. Spits H, Di Santo JP. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12:21-27.
10. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from γδT cells, amplifying Th17 responses and autoimmunity. Immunity 31:331-341.
11. + immune cells in spleen and mucosa. J. Immunol. 185:1177-1185.
12. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. 2013. Innate lymphoid cells: a proposal for uniform nomenclature. Nat. Rev. Immunol. 13:145-149.
13. Eyerich S, Eyerich K, Cavani A, Schmidt-Weber C. 2010. IL-17 and IL-22: siblings, not twins. Trends Immunol. 31:354-361.
14. Renauld JC. 2003. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 3:667-676.
15. Witte E, Witte K, Warszawska K, Sabat R, Wolk K. 2010. Interleukin-22: a cytokine produced by T, NK, and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth FactorRev. 21:365-379.
16. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. 2004. IL-22 increases the innate immunity of tissues. Immunity 21:241-254.
17. Dudakov JA, Hanash AM, Jenq RR, Young LF, Ghosh A, Singer NV, West ML, Smith OM, Holland AM, Tsai JJ, Boyd RL, van den Brink MR. 2012. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336:91-95.
18. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206:1465-1472.
19. Radaeva S, Sun R, Pan HN, Hong F, Gao B. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332-1342.
20. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-544.
21. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-659.
22. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336:1321-1325.
23. Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. 2010. γδ protect against lung fibrosis via IL-22. J. Exp. Med. 207:2239-2253.
24. Hoegl S, Bachmann M, Scheiermann P, Goren I, Hofstetter C, Pfeilschifter J, Zwissler B, Muhl H. 2011. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. Am. J. Respir. Cell Mol. Biol. 44:369-376.
25. Besnard AG, Sabat R, Dumoutier L, Renauld JC, Willart M, Lambrecht B, Teixeira MM, Charron S, Fick L, Erard F, Warszawska K, Wolk K, Quesniaux V, Ryffel B, Togbe D. 2011. Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am. J. Respir. Crit. Care Med. 183:1153-1163.
26. Nakagome K, Imamura M, Kawahata K, Harada H, Okunishi K, Matsumoto T, Sasaki O, Tanaka R, Kano MR, Chang H, Hanawa H, Miyazaki J, Yamamoto K, Dohi M. 2011. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J. Immunol. 187:5077-5089.
27. Takahashi K, Hirose K, Kawashima S, Niwa Y, Wakashin H, Iwata A, Tokoyoda K, Renauld JC, Iwamoto I, Nakayama T, Nakajima H. 2011. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 128:1067-1076.
28. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, Matthys P. 2009. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 60:390-395.
29. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. 2010. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 207:1293-1305.
30. Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L. 2012. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 188:462-469.
31. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-651.
32. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281.
33. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin- 22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.
34. Choi SM, McAleer JP, Zheng M, Pociask DA, Kaplan MH, Qin S, Reinhart TA, Kolls JK. Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J. Exp. Med., in press.
35. Graham AC, Carr KD, Sieve AN, Indramohan M, Break TJ, Berg RE. 2011. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS One 6:e17171. doi:10.1371/journal.pone.0017171.
36. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. 2010. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185:5453-5462.
37. Wilson MS, Feng CG, Barber DL, Yarovinsky F, Cheever AW, Sher A, Grigg M, Collins M, Fouser L, Wynn TA. 2010. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184:4378-4390.
38. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F, Puccetti P, Romani L. 2010. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3:361-373.
39. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34:122-134.
40. Stange J, Hepworth MR, Rausch S, Zajic L, Kuhl AA, Uyttenhove C, Renauld JC, Hartmann S, Lucius R. 2012. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-gamma at the cost of Th17-driven immunopathology. J. Immunol. 188:2410-2418.
41. Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Holscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O. 2009. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206:3047-3059.
42. Arias JF, Nishihara R, Bala M, Ikuta K. 2010. High systemic levels of interleukin-10, interleukin-22, and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses. Retrovirology 7:15.
43. Misse D, Yssel H, Trabattoni D, Oblet C, Lo Caputo S, Mazzotta F, Pene J, Gonzalez JP, Clerici M, Veas F. 2007. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J. Immunol. 178:407-415.
44. Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, Huibner S, Mujib S, Benko E, Kovacs C, Shin LY, Grin A, Kandel G, Loutfy M, Ostrowski M, Gommerman JL, Kaushic C, Kaul R. 2012. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 5:670-680.
45. Dambacher J, Beigel F, Zitzmann K, Heeg MH, Goke B, Diepolder HM, Auernhammer CJ, Brand S. 2008. The role of interleukin-22 in hepatitis C virus infection. Cytokine 41:209-216.
46. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD. 2010. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401:197-206.
47. Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD. 2011. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141:1897-1906.
48. Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan X, Montgomery RR, Flavell RA, Town T, Fikrig E. 2012. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 7:e44153. doi:10.1371/journal.pone.0044153.
49. Guo H, Topham DJ. 2010. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 84:7750-7759.
50. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12:1045-1054.
51. Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, Dumoutier L, Ryffel B, Renauld JC, Gosset P, Gosset P, Si-Tahar M, Faveeuw C, Trottein F. 2012. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287:8816-8829.
52. Kumar P, Thakar MS, Ouyang W, Malarkannan S. 2013. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6:69-82.
53. Ballinger MN, Standiford TJ. 2010. Postinfluenza bacterial pneumonia: host defenses gone awry. J. Interferon Cytokine Res. 30:643-652.
54. Goulding J, Godlee A, Vekaria S, Hilty M, Snelgrove R, Hussell T. 2011. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J. Infect. Dis. 204:1086-1094.
55. Hartshorn KL. 2010. New look at an old problem: bacterial superinfection after influenza. Am. J. Pathol. 176:536-539.
56. McCullers JA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19:571-582.
57. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. 2010. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202:1287-1295.
58. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198:962-970.
59. Snelgrove RJ, Godlee A, Hussell T. 2011. Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol. 32:328-334.
60. van der Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ. 2010. Bench-to-bedside review: bacterial pneumonia with influenza-pathogenesis and clinical implications. Crit. Care 14:219.
61. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280:5571-5580.
62. Marques JM, Rial A, Munoz N, Pellay FX, Van Maele L, Leger H, Camou T, Sirard JC, Benecke A, Chabalgoity JA. 2012. Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-gamma-mediated immunity. Immunobiology 217:420-429.
63. Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, Chabalgoity JA. 2010. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect. Immun. 78:4226-4233.
64. Zemlickova H, Crisostomo MI, Brandileone MC, Camou T, Castaneda E, Corso A, Echaniz-Aviles G, Pasztor M, Tomasz A. 2005. Serotypes and clonal types of penicillin-susceptible streptococcus pneumoniae causing invasive disease in children in five Latin American countries. Microb. Drug Resist. 11:195-204.
65. Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179:8098-8104.
66. + T cells. J. Exp. Med. 205:1381-1393.
67. Sparwasser T, Gong S, Li JY, Eberl G. 2004. General method for the modification of different BAC types and the rapid generation of BAC transgenic mice. Genesis 38:39-50.
68. Dumoutier L, Van Roost E, Colau D, Renauld JC. 2000. Human interleukin- 10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 97:10144-10149.
69. + T cell response during acute influenza A virus H3N2 pneumonia. J. Immunol. 186:5590-5602.
70. + T-cell response is much less apparent following secondary challenge. J. Virol. 74:3486-3493.
71. + dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to alphagalactosylceramide. J. Infect. Dis. 206:723-734.
72. Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA. 2012. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491:259-263.
73. Reynders A, Yessaad N, Vu Manh TP, Dalod M, Fenis A, Aubry C, Nikitas G, Escaliere B, Renauld JC, Dussurget O, Cossart P, Lecuit M, Vivier E, Tomasello E. 2011. Identity, regulation, and in vivo function of gut NKp46 RORt and NKp46 RORt lymphoid cells. EMBO J. 30:2934-2947.
74. Taubenberger JK, Morens DM. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3:499-522.
75. Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Li Q, Kuestner RE, Ozinsky A, Taubenberger JK. 2011. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. mBio 2(5):e00172-11. doi:10.1128/mBio.00172-11.
76. Kadioglu A, Andrew PW. 2004. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 25:143-149.
77. Koppe U, Suttorp N, Opitz B. 2012. Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol. 14:460-466.
78. Kadioglu A, De Filippo K, Bangert M, Fernandes VE, Richards L, Jones K, Andrew PW, Hogg N. 2011. The integrins Mac-1 and alpha4beta1 perform crucial roles in neutrophil and T cell recruitment to lungs during Streptococcus pneumoniae infection. J. Immunol. 186:5907-5915.
79. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, Cavani A, Mempel M, Traidl-Hoffmann C, Eyerich K. 2011. IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 41:1894-1901.
80. Pan HF, Li XP, Zheng SG, Ye DQ. 2013. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev. 24:51-57.